Nuvation Bio Inc Warrants
NUVB.WS
NUVB.WS was delisted on the 10th of February, 2026.
21 hedge funds and large institutions have $3.39M invested in Nuvation Bio Inc Warrants in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 5 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
5% more funds holding
Funds holding: 20 → 21 (+1)
0.33% more ownership
Funds ownership: 1.75% → 2.08% (+0.33%)
23% less capital invested
Capital invested by funds: $4.38M → $3.39M (-$991K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DC
Decheng Capital
Menlo Park,
California
|
+$132K |
| 2 |
LCM
Laurion Capital Management
New York
|
+$34.1K |
| 3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$3.91K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$15.8K |
| 2 |
IP
Intellectus Partners
San Francisco,
California
|
-$6.32K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$2.38K |
| 4 |
6CM
683 Capital Management
New York
|
-$417 |
| 5 |
CAC
Cowen and Company
New York
|
-$132 |
NUVB.WS Hedge Fund Activity: Q2 2024 in Review
21 of the 6,938 institutional investors tracked by Wall St. Rank reported a position in Nuvation Bio Inc Warrants (NUVB.WS) for Q2 2024, worth a combined $3.39M — down 23% from $4.38M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new NUVB.WS positions and 2 closed out — a net gain of 1 holder — while 0 added to existing stakes and 5 trimmed.
The largest buyer was Decheng Capital, opening a new position worth an estimated $132K. The largest seller was Avidity Partners Management, cutting an estimated $15.8K.
- 21 institutional investors held Nuvation Bio Inc Warrants (NUVB.WS) as of Q2 2024, up from 20 in Q1 2024.
- Funds reported $3.39M of Nuvation Bio Inc Warrants stock for Q2 2024, down 23% quarter-over-quarter.
- 3 funds opened new Nuvation Bio Inc Warrants positions in Q2 2024 and 2 closed out, a net change of +1 holder.
- The largest Nuvation Bio Inc Warrants buyer in Q2 2024 was Decheng Capital, an estimated $132K added.
- The largest Nuvation Bio Inc Warrants seller in Q2 2024 was Avidity Partners Management, an estimated $15.8K sold.
Based on aggregated 13F filings for Q2 2024.